跳至主要内容
临床试验/NCT04270968
NCT04270968已完成不适用

Efficacy of Extracorporeal Shock Wave Therapy (ESWT) on Cervical Myofascial Pain Following Neck Dissection Surgery

Qassim University1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2018年11月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
1
主要终点
Visual analogue scale

研究概览

简要总结

Myofascial pain syndrome (MPS) is a musculoskeletal disorder which is characterized by pain, muscle spasms and muscle tenderness, as well as a limited range of motion, weakness, and rarely, autonomous dysfunction.

详细描述

The occurrences of morbidity of the neck after cancer therapy were considerable and consisted of neck pain, loss of sensation, and decreased range of motion. Extracorporeal shock wave therapy (ESWT) is one of the treatment options used for patients with myofascial pain syndrome through elimination of ischemia and modulation of vasoneuroactive substance (two major causes of trigger pathophysiology) and mechanical transduction as a cellular response to external stimulation. the aim of this study was to investigate efficacy of extracorporeal shock wave therapy (ESWT) on cervical myofascial pain following neck dissection surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Previous unilateral modified radical neck dissection.
  • Patients with myofascial pain of upper trapezius for at least 3 months.
  • Patients with palpable intramuscular taut band.
  • Restriction in cervical ROM of lateral flexion and rotation.
  • Provocation of the clinical symptoms by compression of the active trigger point

排除标准

  • Patient who received medication or other therapies for MPS within the previous 2 months.
  • Patients with pacemaker, pregnancy
  • Open wound at the treatment area.
  • Cervical myelopathy or radiculopathy, cervical spine fracture or spondylolisthesis.
  • Rheumatoid arthritis.
  • Coagulopathy.
  • Epilepsy or any psychological disorder.

研究组 & 干预措施

ESWT Group

Experimental

received ESWT once a week for 4 weeks (0.25 ml/mm2, 1000 shocks) plus topical none steroidal anti-inflammatory drug (NSAID; 3 times /day for 4 weeks).

干预措施: extra-corporeal shock wave therapy (Device)

control group

Experimental

received only topical NSAID.

干预措施: topical none steroidal anti-inflammatory drug (Drug)

结局指标

主要结局

Visual analogue scale

时间窗: after 4 weeks of treatment

VAS was utilized for assessing and quantifying pain exhibited by the patients through a 0-10 cm scale. Each subject was informed to mark the line according to the pain intensity experienced at that particular time where '0' means no pain and '10' means worst conceivable pain.

次要结局

  • Cervical range of motion assessment(after 4 weeks of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maged Basha

Assistant Professor, Department of Physical Therapy, College of Medical Rehabilitation, Qassim University, Saudi Arabia, Qassim, Buraidah.

Qassim University

研究点 (1)

Loading locations...

相似试验